10:05 SHANDONG XINHUA<00719> - Announcement (6) "Hong Kong" Hong Kong Special Administrative Region of the PRC "HK$" Hong Kong dollars, the lawful currency of Hong Kong "Independent Board the independent board committee of the Company constituted Committee" for the purpose of the Ongoing Connected Transactions, comprising four independent non-executive directors "Independent shareholders of the Company other than SXPGC and its Shareholders" respective associates (as defined in the Listing Rules) "Listing Rules" the Rules Governing the Listing of Securities on the Stock Exchange "Ongoing Connected the connected transactions entered into between the Company Transactions" and SXPGC on a continuing basis pursuant to the terms of the SXPGC Agreements "PRC" or "China" the People's Republic of China "RMB" or "Renminbi" Renminbi, the lawful currency of the PRC for the time being "Stock Exchange" The Stock Exchange of Hong Kong Limited "SXPGC" * (Shandong Xinhua Pharmaceutical Group Company Limited), a wholly-state owned company which holds and owns 46.89% of the total issued share capital of the Company and is currently the largest shareholder of the Company "SXPGC Agreements" the 2002 Agreement, and the Trademark Licence Agreement; "Trademark Licence the trademark licence agreement entered into between the Agreement" Company and SXPGC on 7th December, 1996; By Order of the Board Shandong Xinhua Pharmaceutical Company Limited Mr. He Duanshi Chairman Zibo, Shandong PRC, 20 April 2005 As at the date hereof, the executive Directors of the Company are Mr. He Duanshi, Mr. Lu Shengmin, Mr. Liu Congde, Ms. Guo Qin, and Mr. Gao Qinggang; and the independent non-executive directors are Mr. Dai Qingjun, Mr. Xiao Yu, Mr. Sun Hua and Mr. Stephen Mok. * For the Chinese name, please refer to the press announcement today.